Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
+0,25%
1 104,10
+2,73
+0,25%
—1 101,371 103,631 105,311 091,41——
SIXC
Communications
SIXC
Communications
SIXC
-1,50%
604,16
-9,19
-1,50%
—613,35613,35613,35601,49——
SIXE
Energy
SIXE
Energy
SIXE
-0,09%
1 197,81
-1,02
-0,09%
—1 198,831 199,681 199,751 182,41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,88%
1 740,41
-15,54
-0,88%
—1 755,951 754,061 756,031 734,69——
SIXM
Financials
SIXM
Financials
SIXM
-0,64%
634,44
-4,07
-0,64%
—638,51637,41637,41633,05——
SIXR
Staples
SIXR
Staples
SIXR
-0,31%
840,90
-2,62
-0,31%
—843,52843,35846,40837,93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,38%
215,13
-0,82
-0,38%
—215,95215,95216,84215,06——
SIXT
Technology
SIXT
Technology
SIXT
+2,86%
3 228,71
+89,80
+2,86%
—3 138,913 189,303 230,853 174,76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,16%
935,87
+1,50
+0,16%
—934,37934,72938,26927,50——
SIXV
Health care
SIXV
Health care
SIXV
-1,37%
1 457,12
-20,31
-1,37%
—1 477,431 474,121 474,121 451,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,83%
2 399,84
+19,65
+0,83%
—2 380,192 389,342 403,042 380,47——
GRFS:NASDAQ
Grifols SA - ADR ADR Class B
8,08 US$
+1,13%
(+0,090) 1K
8,15 US$
+0,87% (+0,070)
Yopilgandan keyin
Savdolar yopilgan: 24-apr, 16:00:01 (GMT-4)  ·   USD
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
GRFS tikeri uchun statistika yaratilmoqda...
Ochish
8,08 US$
Yuqori
8,12 US$
Past
7,97 US$
Bozor kapitali
6,69 mlrd
Oʻrtacha hajm
745,20 ming
Hajmi
343,90 ming
Dividend
2,18%
Choraklik dividendlar
0,04 US$
Eks-dividend sanasi
11-avg, 2025
P/E koeffitsiyenti
11,71
52 haftalik eng yuqori
11,14 US$
52 haftalik eng past
6,90 US$
Aksiya boʻyicha daromad
0,69 US$
Beta
0,71
Muomaladagi aksiyalar
261,42 mln
Xodimlar soni
25 ming
Yangiliklar
Internetdagi manbalardan
Profil
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Grifols SA - ADR ADR Class B haqida
CEONacho Abia
Xodimlar soni25,3 ming
Asos solingan18-noy, 1940
Bosh ofislar-
Sektor-
Veb-saytgrifols.com
Oxirgi hisobot
26-fev, 2026
Moliya davri
Ch.4 2025
Normallashtirilgan EPS / Taxminiy
0,33/ -EUR
0,00%manfiy
Daromad / Taxminan
7,52 mlrd/ (1,96 mlrd taxm.)EUR
+283,96%musbat
Q4 2025 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
QisqachaOxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar – EUR
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – EUR
mar, 2025
iyn, 2025
sen, 2025
dek, 2025
Daromad
1,79 mlrd
1,89 mlrd
1,87 mlrd
1,98 mlrd
Sotilgan mahsulotning tannarxi
1,08 mlrd
1,15 mlrd
1,11 mlrd
1,28 mlrd
Daromad narxi
1,08 mlrd
1,15 mlrd
1,11 mlrd
1,28 mlrd
Tadqiqot va ishlanmalarga xarajatlar
96,05 mln
96,19 mln
97,01 mln
90,82 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
315,37 mln
298,06 mln
273,76 mln
262,86 mln
Operatsion xarajatlar
411,42 mln
394,25 mln
370,34 mln
353,11 mln
Jami operatsion xarajatlar
1,49 mlrd
1,54 mlrd
1,48 mlrd
1,63 mlrd
Operatsion daromad
293,22 mln
349,54 mln
381,18 mln
347,38 mln
Boshqa nooperatsion daromad
-
8,08 mln
-
-33,00 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
115,26 mln
190,51 mln
198,13 mln
111,10 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
134,52 mln
190,51 mln
227,20 mln
183,10 mln
Daromad soligʻi boʻyicha xarajat
22,84 mln
52,13 mln
54,71 mln
-14,68 mln
Amaldagi soliq stavkasi
19,82%
27,36%
27,61%
-13,21%
Boshqa operatsion xarajatlar
-
-
-430,00 ming
-570,00 ming
Sof foyda
59,72 mln
117,06 mln
126,96 mln
98,25 mln
Sof foyda marjasi
3,34%
6,19%
6,81%
4,96%
Har bir aksiya foydasi
-
0,19
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
9,56 mln
-
36,00 mln
Foizlarni toʻlash xarajatlari
-153,59 mln
-141,43 mln
-156,07 mln
-107,99 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-153,59 mln
-131,88 mln
-156,07 mln
-71,99 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
404,97 mln
414,24 mln
484,03 mln
422,88 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
732,00 ming
-
2,00 mln
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish